Ascendis Health Limited

As of June 30, 2023, Ascendis Health Limited has 626.05M shares outstanding.

As of June 30, 2023, Ascendis Health Limited maintains a current ratio of 1.97, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.98, indicating elevated leverage, while an interest coverage ratio of -4.36 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2023, Ascendis Health Limited posted a return on equity (ROE) of 15.34, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 5.69, measuring how efficiently the asset base is converted into earnings. Inventory turnover of 2.52 indicates how many times Ascendis Health Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on November 28, 2025, Ascendis Health Limited's stock has gained approximately 16.46% over the past 52 weeks. The 50-day moving average sits at 92.94, while the 200-day moving average is 85.94.

Over the twelve months ended June 30, 2023, Ascendis Health Limited posted a gross margin of 39.37, reflecting its pricing power and cost economics. The operating margin of -12.86 and net profit margin of 4.91 provide insight into operational efficiency.

Ascendis Health Limited's most recent stock split took place on August 10, 2022 with a 250:253 split ratio.

As of June 30, 2023, Ascendis Health Limited has an Altman Z-Score of -6.95, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.